{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:50:23Z","timestamp":1788922223946,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ejphar.2025.177766","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T23:22:08Z","timestamp":1747956128000},"page":"177766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The interplay between Kynurenine and Nociceptin\/Orphanin FQ pathways can be related to depressive-like phenotype"],"prefix":"10.1016","volume":"1001","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1974-4363","authenticated-orcid":false,"given":"Alice Barros","family":"C\u00e2mara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1823-5014","authenticated-orcid":false,"given":"Igor Augusto","family":"Brand\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177766_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-014-0151-1","article-title":"The common inflammatory etiology of depression and cognitive impairment: a therapeutic target","volume":"11","author":"Allison","year":"2014","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177766_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/sc.2016.96","article-title":"Targeting inflammation to influence cognitive function following spinal cord injury: a randomized clinical trial","volume":"55","author":"Allison","year":"2017","journal-title":"Spinal Cord"},{"key":"10.1016\/j.ejphar.2025.177766_bib3","author":"Almende"},{"issue":"5762","key":"10.1016\/j.ejphar.2025.177766_bib4","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1120972","article-title":"Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress","volume":"311","author":"Berton","year":"2006","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ejphar.2025.177766_bib5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0306-4522(03)00484-6","article-title":"[3H]-nociceptin ligand-binding and nociceptin opioid receptor mRNA expression in the human brain","volume":"121","author":"Berthele","year":"2003","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177766_bib6","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1742-4658.2009.07487.x","article-title":"Neuroprotective effects of naturally occurring polyphenols on quinolinic acid-induced excitotoxicity in human neurons","volume":"277","author":"Braidy","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.ejphar.2025.177766_bib7","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.neubiorev.2021.05.018","article-title":"The kynurenine pathway in major depression: what we know and where to next","volume":"127","author":"Brown","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177766_bib8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1037\/bne0000539","article-title":"Behavioral and neurochemical effects of nociceptin\/orphanin FQ receptor activation in the social defeat protocol","volume":"137","author":"C\u00e2mara","year":"2023","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177766_bib9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jpsychires.2025.02.012","article-title":"The neuroinflammatory effects of Nociceptin\/Orphanin FQ receptor activation can be related to depressive-like behavior","volume":"183","author":"C\u00e2mara","year":"2025","journal-title":"J. Psychiatr. Res."},{"issue":"15","key":"10.1016\/j.ejphar.2025.177766_bib10","doi-asserted-by":"crossref","first-page":"8493","DOI":"10.3390\/ijms23158493","article-title":"Tryptophan metabolism in depression: a narrative review with a focus on serotonin and kynurenine pathways","volume":"23","author":"Correia","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177766_bib11","first-page":"1","article-title":"The igraph software package for complex network research","volume":"1695","author":"Csardi","year":"2006","journal-title":"Inte.J.Complex Sys."},{"key":"10.1016\/j.ejphar.2025.177766_bib12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.intimp.2019.05.039","article-title":"Interaction of the immune-inflammatory and the kynurenine pathways in rats resistant to antidepressant treatment in model of depression","volume":"73","author":"Duda","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177766_bib13","first-page":"516","article-title":"Investigating network robustness through node removal: an algorithmic and experimental analysis","volume":"7","author":"Farina","year":"2019","journal-title":"J.Complex Netw."},{"key":"10.1016\/j.ejphar.2025.177766_bib14","article-title":"IDO and kynurenine metabolites in peripheral and CNS disorders","volume":"11","author":"Huang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177766_bib15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.neubiorev.2020.08.010","article-title":"Effect of immune activation on the kynurenine pathway and depression Symptoms\u2013a systematic review and meta-analysis","volume":"118","author":"Hunt","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2025.177766_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2019.104371","article-title":"Kynurenine metabolism and inflammation-induced depressed mood: a human experimental study","volume":"109","author":"Kruse","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ejphar.2025.177766_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-10-87","article-title":"Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors","volume":"10","author":"Lawson","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2025.177766_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.brainres.2013.05.005","article-title":"Acute and subchronic treatments with selective serotonin reuptake inhibitors increase Nociceptin\/Orphanin FQ (NOP) receptor density in the rat dorsal raphe nucleus; interactions between nociceptin\/NOP system and serotonin","volume":"1520","author":"Le Ma\u00eetre","year":"2013","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177766_bib19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/jnr.20571","article-title":"Opioid receptor\u2010like 1 (NOP) receptors in the rat dorsal raphe nucleus: evidence for localization on serotoninergic neurons and functional adaptation after 5,7\u2010dihydroxytryptamine lesion","volume":"81","author":"Le Ma\u00eetre","year":"2005","journal-title":"J. Neurosci. Res."},{"issue":"1\u20133","key":"10.1016\/j.ejphar.2025.177766_bib20","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jad.2011.08.023","article-title":"IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: new pathways that underpin the inflammatory and neuroprogressive pathophysiology","volume":"135","author":"Maes","year":"2011","journal-title":"J. Affect. Disord."},{"issue":"16","key":"10.1016\/j.ejphar.2025.177766_bib21","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0024-3205(02)01853-2","article-title":"Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation","volume":"71","author":"Maes","year":"2002","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177766_bib22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1440-1681.2008.05077.x","article-title":"Kynurenine metabolites and inflammation markers in depressed patients treated with fluoxetine or counselling","volume":"36","author":"Mackay","year":"2009","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"9","key":"10.1016\/j.ejphar.2025.177766_bib23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/15622975.2018.1468031","article-title":"Reduced peripheral availability of tryptophan and increased activation of the kynurenine pathway and cortisol correlate with major depression and suicide","volume":"20","author":"Messaoud","year":"2019","journal-title":"World J. Biol. Psychiatr."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177766_bib24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/10253890701754068","article-title":"A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression","volume":"11","author":"Miura","year":"2008","journal-title":"Stress"},{"issue":"6","key":"10.1016\/j.ejphar.2025.177766_bib25","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s12031-022-02004-y","article-title":"COVID-19, oxidative stress, and neuroinflammation in the depression route","volume":"72","author":"Mingoti","year":"2022","journal-title":"J. Mol. Neurosci."},{"issue":"7","key":"10.1016\/j.ejphar.2025.177766_bib26","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3390\/cells10071603","article-title":"Role of kynurenine pathway in oxidative stress during neurodegenerative disorders","volume":"10","author":"Mor","year":"2021","journal-title":"Cells"},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2025.177766_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","article-title":"Kynurenine pathway in major depression: evidence of impaired neuroprotection","volume":"98","author":"Myint","year":"2007","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177766_bib28","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1177\/02698811231173588","article-title":"The interaction between kynurenine pathway, suicidal ideation and augmentation therapy with minocycline in patients with treatment-resistant depression","volume":"37","author":"Nettis","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2025.177766_bib29","first-page":"1","article-title":"RColorBrewer: colorbrewer palettes","volume":"1","author":"Neuwirth","year":"2014","journal-title":"R Package Version"},{"issue":"5","key":"10.1016\/j.ejphar.2025.177766_bib30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.mp.4002148","article-title":"Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice","volume":"14","author":"O'Connor","year":"2009","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177766_bib31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1471-4159.1998.70010299.x","article-title":"3\u2010Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity","volume":"70","author":"Okuda","year":"1998","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177766_bib32","first-page":"56","article-title":"Tryptophan\u2013kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later","volume":"47","author":"Oxenkrug","year":"2010","journal-title":"Isr. J. Psychiatr. Relat. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177766_bib33","doi-asserted-by":"crossref","first-page":"437","DOI":"10.7705\/biomedica.v38i3.3688","article-title":"A new theory of depression based on the serotonin\/kynurenine relationship and the hypothalamic-pituitary-adrenal axis","volume":"38","author":"Ram\u00edrez","year":"2018","journal-title":"Biomedica"},{"issue":"16","key":"10.1016\/j.ejphar.2025.177766_bib34","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1089\/ars.2021.0215","article-title":"Kynurenine\/aryl hydrocarbon receptor modulates mitochondria-mediated oxidative stress and neuronal apoptosis in experimental intracerebral hemorrhage","volume":"37","author":"Ren","year":"2022","journal-title":"Antioxidants Redox Signal."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177766_bib35","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/s41598-020-58806-w","article-title":"Serum metabolic profiles of the tryptophan-kynurenine pathway in the high-risk subjects of major depressive disorder","volume":"10","author":"Sakurai","year":"2020","journal-title":"Sci. Rep."},{"issue":"D1","key":"10.1016\/j.ejphar.2025.177766_bib36","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177766_bib37","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0021-9258(19)77982-4","article-title":"Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity","volume":"263","author":"Takikawa","year":"1988","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.ejphar.2025.177766_bib38","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3390\/biomedicines9070734","article-title":"Immune influencers in action: metabolites and enzymes of the tryptophan-kynurenine metabolic pathway","volume":"9","author":"Tanaka","year":"2021","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.ejphar.2025.177766_bib39","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s40263-021-00821-0","article-title":"The NOP receptor system in neurological and psychiatric disorders: discrepancies, peculiarities and clinical progress in developing targeted therapies","volume":"35","author":"Toll","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2025.177766_bib40","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.bbi.2020.04.016","article-title":"Kynurenine regulates NLRP2 inflammasome in astrocytes and its implications in depression","volume":"88","author":"Zhang","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejphar.2025.177766_bib41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbi.2018.09.007","article-title":"Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression","volume":"74","author":"Zhou","year":"2018","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177766_bib42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.numecd.2014.11.004","article-title":"Impact of cholesterol lowering treatment on plasma kynurenine and tryptophan concentrations in chronic kidney disease: relationship with oxidative stress improvement","volume":"25","author":"Zinellu","year":"2015","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177766_bib43","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/s41598-024-52442-4","article-title":"Causal association between kynurenine and depression investigated using two-sample Mendelian randomization","volume":"14","author":"Zong","year":"2024","journal-title":"Sci. Rep."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925005205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925005205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T07:57:40Z","timestamp":1749283060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925005205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":43,"alternative-id":["S0014299925005205"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177766","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The interplay between Kynurenine and Nociceptin\/Orphanin FQ pathways can be related to depressive-like phenotype","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177766","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177766"}}